The Role of Product Development Partnerships in Advancing the Development of Drugs for Unmet Needs

被引：10

作者：

Breitstein, J. ^{[1
]}

Spigelman, M. ^{[1
]}

机构：

[1] Global Alliance TB Drug Dev, New York, NY USA

来源：

关键词：

NEGLECTED DISEASES;

D O I：

10.1038/clpt.2013.53

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：468 / 470

页数：3

共 5 条

[1]

Looney W., 2011, PHARM EXEC

[2]

Ponder E, 2012, DEV NEW DRUGS VACCIN

Trouiller, P ;

Olliaro, P ;

Torreele, E ;

Orbinski, J ;

Laing, R ;

Ford, N .

[4] Neglected diseases see few new drugs despite upped investment [J].

Willyard, Cassandra .

[5] Development of Novel Combination Therapies [J].

Woodcock, Janet ;

Griffin, Joseph P. ;

Behrman, Rachel E. .